Turn this list into an evaluation

Each entry is an FDA submission, not a distinct commercial offer. Inspect the exact record before comparing evidence, asking for a quote or planning an integration.

Prepare with a buyer guide:

Clinical guide links appear when this list contains a current reviewed example. They do not classify or endorse the other entries. All buyer guides · Compare exact records · Documented families

FDA-cleared K242683

QP-Prostate® CAD

Quibim S.L.

Authorized purpose: QP-Prostate CAD detects and marks suspected prostate lesions for clinically significant prostate cancer on bi-parametric T2-weighted and diffusion-weighted prostate MRI, returning moderate/high suspicion overlays in DICOM to third-party workstations/PACS for concurrent physician review; patient management must not rely on it alone.

Modality
MRI
Anatomy
Prostate
Decision
2025-03-18
FDA-cleared K232231

QP-Brain®

Quibim S.L.

Authorized purpose: Automatically label and volumetrically quantify segmentable brain structures and white matter hyperintensities (WMH) from MR images in adults and adolescents aged 18 years and older, as a support tool for properly trained clinicians assessing structural MRIs; patient-management decisions must not rely solely on the device results.

Modality
MRI
Anatomy
Brain
Decision
2023-12-13
FDA-cleared K203582

QUIBIM Precision Prostate (qp-Prostate)

QUIBIM S.L.

Authorized purpose: Views, processes, and analyzes prostate MR images for trained professionals; it is not diagnostic and decisions should not rely solely on its results.

Modality
MRI
Anatomy
Prostate
Decision
2021-02-04